No Data
Jefferies Maintains Phathom Pharmaceuticals(PHAT.US) With Buy Rating, Cuts Target Price to $13
Jefferies Cuts Price Target on Phathom Pharmaceuticals to $13 From $17, Maintains Buy Rating
Phathom Pharmaceuticals: Favorable Risk/Reward Profile Amid Challenges and Growth Opportunities
Phathom Pharmaceuticals Shares Are Trading Higher. A Filing Disclosed That a Director Purchased 10,000 Shares at an Average Price of $4.42 per Share.
Express News | Form4 Shows Phathom Pharmaceuticals Director Asit Parikh Purchased 10,000 Shares At Avg. Price $4.42
Director's Bold Move: Major Stock Purchase at Phathom Pharmaceuticals!
!![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
PYUN970IHaveChosen OP : Work the numbers not the system!
TheFather : Just keeps on giving back
PYUN970IHaveChosen OP TheFather : That’s how your system works!!!![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined")
The Father! GL to All
!
Xyno : you bought for 2.47? when was the price that low?
PYUN970IHaveChosen OP Xyno : No,no, that is my diluted cost. I have been holding for sometime! GL to ALL
!